Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion Leave a Comment / By shafinmd808@gmail.com Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
